CVS Group profit drops 7.4% as revenue rises on Australia expansion, asset sale
Tenet Healthcare Corporation stock reached a 52-week high of 200.19 USD, marking a significant milestone for the company. The healthcare provider’s impressive performance includes a 55.84% gain year-to-date and a robust 47.87% surge over the past six months. Over the past year, the stock has experienced a notable increase, with a 1-year change of 21.88%. This upward trend reflects a period of growth and positive investor sentiment for Tenet Healthcare, underscoring its resilience and potential in the healthcare sector. With a market capitalization of $17.63 billion and an attractive P/E ratio of 12.33, the company maintains a "GREAT" financial health score according to InvestingPro analysis. The recent high suggests strong market confidence, as the company continues to navigate the complexities of the industry while capitalizing on emerging opportunities. Discover 12 additional exclusive insights and detailed valuation metrics with InvestingPro.
In other recent news, Tenet Healthcare has seen several updates from prominent analyst firms. Cantor Fitzgerald has reiterated its Overweight rating on Tenet Healthcare with a price target of $190, noting an elevated physician bonus trend in the third quarter of 2025. The firm also expressed caution regarding the 2026 Marketplace environment, highlighting that finalized rates align with payor proposals but fall below initial expectations. Despite potential challenges with the Affordable Care Act marketplace, Cantor Fitzgerald maintains its Overweight rating, focusing on the impact of premium increases on Health Insurance Exchange enrollment, which constitutes a small portion of Tenet’s revenue.
RBC Capital also raised its price target for Tenet Healthcare from $189 to $230, maintaining an Outperform rating and citing strong growth potential and an enhanced capital structure. The firm emphasized Tenet as its top pick in the hospital sector, noting a valuation discount compared to HCA Healthcare. These developments underscore the varied perspectives on Tenet Healthcare’s future amid evolving market conditions and strategic evaluations by analysts.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.